John S. (Pete)
Lollar III,
M.D.
Director, Hemostasis Research
Egleston
|
Education and Training
Medical Degree:
St. Louis University,
St. Louis,
MO,
1977
Residency:
Internal Medicine,
University of Iowa,
Iowa City,
IA,
1980-1982
Fellowship:
Hematology,
University of Iowa,
Iowa City,
IA,
1978-1980
Hematology,
Mayo Clinic
1982-1984
Certifications
-
Internal Medicine
-
Subspecialty of Hematology
Professional Scientific Societies
- American Society of Hematology
- American Society for Biochemistry and Molecular Biology
- American Chemical Society
- The Protein Society
- American Society for Clinical Investigation
- International Society on Thrombosis and Haemostasis
Awards/Honors
- American Heart Association, Established Investigator Award, 1987-92
- American Heart Association National Peer Review Committee (Thrombosis), 2001- 2004
- Holder/co-holder of 10 United States patents
Areas of Interest
- Development of improved treatment for patients with hemophilia
- Blood coagulation
- Cofounded a biotechnology company, Octagen, which licensed technology from Emory University to develop novel recombinant factor VIII molecules.
Privileges
Egleston